Artiva Biotherapeutics, Inc.
ARTV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $70,263 | $36,812 | $73,026 | $245,580 |
| - Cash | $25,508 | $28,468 | $30,401 | $40,235 |
| + Debt | $11,691 | $13,224 | $13,996 | $14,354 |
| Enterprise Value | $56,446 | $21,568 | $56,621 | $219,699 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$662 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$20,866 | -$22,169 | -$21,543 | -$17,653 |
| % Margin | – | – | – | – |
| Net Income | -$21,528 | -$21,254 | -$20,311 | -$9,215 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.88 | -0.87 | -0.83 | -0.82 |
| % Growth | -1.1% | -4.8% | -1.2% | – |
| Operating Cash Flow | -$19,201 | -$22,983 | -$19,841 | -$14,650 |
| Capital Expenditures | -$600 | -$1,055 | -$511 | -$64 |
| Free Cash Flow | -$19,801 | -$24,038 | -$20,352 | -$14,714 |